Day One Reports Second Quarter 2025 Financial Results and Corporate Progress

BRISBANE, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) ("Day One" or the "Company"), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced its second quarter 2025 financial results and highlighted recent corporate achievements. "We have strong momentum going into the second half of 2025. We continue to focus on our three core priorities: accelerating revenu ...